ACVC Premium Access

Therapeutic versus prophylactic anticoagulation in patients with COVID-19: a meta-analysis of randomised controlled trials

Congress Presentation

About the speaker

Professor Ryota Sakurai

Graduate School of Public Health, International University of Health and Welfare, Tokyo (Japan)
0 follower

5 more presentations in this session

Short term impact of COVID-19 pneumonia in patients with reduced left ventricular ejection fraction (LVEF)

Speaker: Doctor S. THANGASAMI (Chennai, IN)


New-onset atrial fibrillation predicts poor prognosis in critically ill COVID-19 patients

Speaker: Doctor V. Lopes (Coimbra, PT)


Chest pain post anti-Covid-19 vaccination with mRNA BNT162b2 vaccine : the experience of a secondary hospital

Speaker: Doctor M. Stratinaki (Heraklion, GR)


Elevation in troponin associated with COVID-19 is associated with an adverse long-term outcome

Speaker: Doctor A. Deshpande (London, GB)


Recurrent myocardial injury is a strong predictor of ICU mortality in COVID-19.

Speaker: Doctor F. De Roeck (Edegem, BE)


Access the full session

COVID-19 - here to stay?

Speakers: Professor R. Sakurai, Doctor S. THANGASAMI, Doctor V. Lopes, Doctor M. Stratinaki, Doctor A. Deshpande...

About the event


ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

Sessions Presentations

Related content

ESC Premium Access

The clinical view: when would I consider renal denervation?

30 August 2021

ESC Premium Access

Renal denervation: mechanisms, methods and evidence.

30 August 2021

ESC Premium Access

Antithrombotic regime in ACS and CCS patients.

29 August 2021

ESC 365 is supported by

logo Novo Nordisk